Emcure Pharmaceuticals signs distribution pact with Roche for nephrology, transplant medicine
Emcure Pharmaceuticals signs distribution pact with Roche for nephrology, transplant medicine is drawing significant interest across the industry.
NEW DELHI, Mar 2: Emcure Pharmaceuticals on Monday said it has signed a distribution agreement with Roche for select products in the nephrology and transplant medicine portfolio. Under the agreement, effective April 1, 2026, Emcure will distribute Roche’s established and globally recognised brands in the nephrology and transplant segment in India, Emcure Pharmaceuticals said in a regulatory filing. The agreement includes brands ‘CellCept’ – a globally leading immunosuppressant and original Roche innovation, supporting organ transplants worldwide since 1995, along with […]
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Related Articles
- Oil Drops As US And Iran Prepare For Further Nuclear Talks
- Erin Jackson, Jordan Stolz share how they keep happiness at the forefront
- Smart glasses in court are a privacy nightmare
- Study finds most YouTube advice on morning sickness lacks scientific evidence and some may pose risks
Source: Original →